Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
In conclusion, our study conducted within real-world clinical settings revealed a noteworthy association between the use of GLP-1 RAs, including Liraglutide and Semaglutide, and a heightened risk of psychiatric outcomes, encompassing depression, anxiety, and suicidal behaviour
Patients should be reassured that experiencing some degree of tiredness during the initial treatment phase is not uncommon and does not necessarily indicate treatment failure or serious adverse effects
3 Results 3.1 Characteristics of the included studies The search included 331 potentially relevant articles after examining the titles/summary, excluding 290 studies because they were duplicate publications or because they did not evaluate the purpose of this study
Clinician oversight is essential in initiating, adjusting, and monitoring peptide therapy
Bariatric surgery Weight loss surgery is a safe and common approach to addressing obesity
